Update on sepsis: Pathophysiology and treatment

被引：18

作者：

Vincent, JL ^{[1
]}

机构：

[1] Free Univ Brussels, Erasme Hosp, Dept Intens Care, B-1050 Brussels, Belgium

来源：

ACTA CLINICA BELGICA | 2000年 / 55卷 / 02期

关键词：

cytokines; inflammatory response; nitric oxide;

D O I：

10.1080/17843286.2000.11754275

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Sepsis results from the activation of a complex cascade of mediators, an appropriate and necessary body response to infection or insult which can, however, become excessive and detrimental to the host. When the immunological host response is not well controlled, it may lead to multiple organ failure and death. This manuscript reviews the epidemiology and the major factors involved in the development of sepsis, and considers a number of therapeutic interventions that may help to better control the septic process and the related development of multiple organ failure.

引用

页码：79 / 87

页数：9

共 70 条

[1]

Abraham E, 1998, LANCET, V351, P929

[2] p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial [J].

Abraham, E ;

Glauser, MP ;

Butler, T ;

Garbino, J ;

Gelmont, D ;

Laterre, PF ;

Kudsk, K ;

Bruining, HA ;

Otto, C ;

Tobin, E ;

Zwingelstein, C ;

Lesslauer, W ;

Leighton, A .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19) :1531-1538

[3]

Al-Nawas B, 1996, Eur J Med Res, V1, P331

[4]

ANDERSON BO, 1991, SURG GYNECOL OBSTET, V172, P415

[5] HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].

ASSICOT, M ;

GENDREL, D ;

CARSIN, H ;

RAYMOND, J ;

GUILBAUD, J ;

BOHUON, C .

LANCET, 1993, 341 (8844) :515-518

[6] DIVERGENT EFFICACY OF ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA IN INTRAVASCULAR AND PERITONITIS MODELS OF SEPSIS [J].

BAGBY, GJ ;

PLESSALA, KJ ;

WILSON, LA ;

THOMPSON, JJ ;

NELSON, S .

JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (01) :83-88

[7] Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study [J].

Baudo, F ;

Caimi, TM ;

de Cataldo, F ;

Ravizza, A ;

Arlati, S ;

Casella, G ;

Carugo, D ;

Palareti, G ;

Legnani, C ;

Ridolfi, L ;

Rossi, R ;

D'Angelo, A ;

Crippa, L ;

Giudici, D ;

Gallioli, G ;

Wolfler, A ;

Calori, G .

INTENSIVE CARE MEDICINE, 1998, 24 (04) :336-342

[8] INTERLEUKIN-1-BETA AND TUMOR-NECROSIS-FACTOR-ALPHA SYNERGISTICALLY INDUCE NO SYNTHASE IN RAT VASCULAR SMOOTH-MUSCLE CELLS [J].

BEASLEY, D ;

ELDRIDGE, M .

AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :R1197-R1203

[9] The effects of ibuprofen on the physiology and survival of patients with sepsis [J].

Bernard, GR ;

Wheeler, AP ;

Russell, JA ;

Schein, R ;

Summer, WR ;

Steinberg, KP ;

Fulkerson, WJ ;

Wright, PE ;

Christman, BW ;

Dupont, WD ;

Higgins, SB ;

Swindell, BB .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) :912-918

[10] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].

BONE, RC ;

BALK, RA ;

CERRA, FB ;

DELLINGER, RP ;

FEIN, AM ;

KNAUS, WA ;

SCHEIN, RMH ;

SIBBALD, WJ ;

ABRAMS, JH ;

BERNARD, GR ;

BIONDI, JW ;

CALVIN, JE ;

DEMLING, R ;

FAHEY, PJ ;

FISHER, CJ ;

FRANKLIN, C ;

GORELICK, KJ ;

KELLEY, MA ;

MAKI, DG ;

MARSHALL, JC ;

MERRILL, WW ;

PRIBBLE, JP ;

RACKOW, EC ;

RODELL, TC ;

SHEAGREN, JN ;

SILVER, M ;

SPRUNG, CL ;

STRAUBE, RC ;

TOBIN, MJ ;

TRENHOLME, GM ;

WAGNER, DP ;

WEBB, CD ;

WHERRY, JC ;

WIEDEMANN, HP ;

WORTEL, CH .

CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874

← 1 2 3 4 5 6 7 →